Kewaunee Scientific (KEQU)
(Delayed Data from NSDQ)
$53.35 USD
-1.36 (-2.49%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $53.00 -0.35 (-0.66%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KEQU 53.35 -1.36(-2.49%)
Will KEQU be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KEQU based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KEQU
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
KEQU Reports Y/Y Earnings Decline in Q3 Despite Strong Sales Growth
KEQU: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
The Zacks Analyst Blog The Home Depot, RTX, Applied Materials, Kewaunee Scientific and AXIL Brands
Other News for KEQU
Insider Sell: Gardner Donald T. III Sells 3,000 Shares of Kewaunee Scientific Corp (KEQU)
Kewaunee Scientific: Huge Improvement In Operational Outlook (Upgrade To Buy)
12 Health Care Stocks Moving In Thursday's Intraday Session
Kewaunee Scientific Reports Strong Fiscal Year 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session